Intuitive Surgical Debt to Equity Ratio 2006-2019 | ISRG
Current and historical debt to equity ratio values for Intuitive Surgical (ISRG) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Intuitive Surgical debt/equity for the three months ending March 31, 2019 was 0.00.
| Intuitive Surgical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-03-31 | $0.00B | $7.04B | 0.00 |
| 2018-12-31 | $0.00B | $6.69B | 0.00 |
| 2018-09-30 | $0.00B | $6.29B | 0.00 |
| 2018-06-30 | $0.00B | $5.87B | 0.00 |
| 2018-03-31 | $0.00B | $5.51B | 0.00 |
| 2017-12-31 | $0.00B | $4.78B | 0.00 |
| 2017-09-30 | $0.00B | $4.96B | 0.00 |
| 2017-06-30 | $0.00B | $4.52B | 0.00 |
| 2017-03-31 | $0.00B | $4.13B | 0.00 |
| 2016-12-31 | $0.00B | $5.78B | 0.00 |
| 2016-09-30 | $0.00B | $5.54B | 0.00 |
| 2016-06-30 | $0.00B | $5.18B | 0.00 |
| 2016-03-31 | $0.00B | $4.75B | 0.00 |
| 2015-12-31 | $0.00B | $4.32B | 0.00 |
| 2015-09-30 | $0.00B | $4.12B | 0.00 |
| 2015-06-30 | $0.00B | $3.79B | 0.00 |
| 2015-03-31 | $0.00B | $3.59B | 0.00 |
| 2014-12-31 | $0.00B | $3.38B | 0.00 |
| 2014-09-30 | $0.00B | $3.08B | 0.00 |
| 2014-06-30 | $0.00B | $2.82B | 0.00 |
| 2014-03-31 | $0.00B | $3.66B | 0.00 |
| 2013-12-31 | $0.00B | $3.50B | 0.00 |
| 2013-09-30 | $0.00B | $3.26B | 0.00 |
| 2013-06-30 | $0.00B | $3.72B | 0.00 |
| 2013-03-31 | $0.00B | $3.77B | 0.00 |
| 2012-12-31 | $0.00B | $3.58B | 0.00 |
| 2012-09-30 | $0.00B | $3.29B | 0.00 |
| 2012-06-30 | $0.00B | $3.18B | 0.00 |
| 2012-03-31 | $0.00B | $2.93B | 0.00 |
| 2011-12-31 | $0.00B | $2.65B | 0.00 |
| 2011-09-30 | $0.00B | $2.37B | 0.00 |
| 2011-06-30 | $0.00B | $2.29B | 0.00 |
| 2011-03-31 | $0.00B | $2.23B | 0.00 |
| 2010-12-31 | $0.00B | $2.04B | 0.00 |
| 2010-09-30 | $0.00B | $2.01B | 0.00 |
| 2010-06-30 | $0.00B | $1.92B | 0.00 |
| 2010-03-31 | $0.00B | $1.77B | 0.00 |
| 2009-12-31 | $0.00B | $1.54B | 0.00 |
| 2009-09-30 | $0.00B | $1.39B | 0.00 |
| 2009-06-30 | $0.00B | $1.27B | 0.00 |
| 2009-03-31 | $0.00B | $1.18B | 0.00 |
| 2008-12-31 | $0.00B | $1.27B | 0.00 |
| 2008-09-30 | $0.00B | $1.18B | 0.00 |
| 2008-06-30 | $0.00B | $1.07B | 0.00 |
| 2008-03-31 | $0.00B | $0.98B | 0.00 |
| 2007-12-31 | $0.00B | $0.89B | 0.00 |
| 2007-09-30 | $0.00B | $0.80B | 0.00 |
| 2007-06-30 | $0.00B | $0.71B | 0.00 |
| 2007-03-31 | $0.00B | $0.64B | 0.00 |
| 2006-12-31 | $0.00B | $0.59B | 0.00 |
| 2006-09-30 | $0.00B | $0.54B | 0.00 |
| 2006-06-30 | $0.00B | $0.50B | 0.00 |
| 2006-03-31 | $0.00B | $0.47B | 0.00 |
| 2005-12-31 | $0.00B | $0.44B | 0.00 |
| 2005-09-30 | $0.00B | $0.38B | 0.00 |
| 2005-06-30 | $0.00B | $0.35B | 0.00 |
| 2005-03-31 | $0.00B | $0.33B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $58.664B | $3.724B |
| Intuitive Surgical, Inc. is the global technology leader in minimally invasive robotic-assisted surgery. The Company's da Vinci Surgical System enables surgeons to operate minimally invasively through a few small incisions or the belly button from a nearby ergonomic console. The da Vinci System features a magnified 3D HD vision system and tiny wristed instruments that bend and rotate far greater than the human hand. As a result of this technology, da Vinci enables surgeons to operate with enhanced vision, precision and control. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $104.363B | 22.88 |
| Edwards Lifesciences (EW) | United States | $36.977B | 37.03 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.585B | 16.83 |
| IDEXX Laboratories (IDXX) | United States | $19.324B | 52.60 |
| Hologic (HOLX) | United States | $13.031B | 19.70 |
| Teleflex (TFX) | United States | $12.848B | 28.14 |
| ABIOMED (ABMD) | United States | $12.211B | 80.60 |
| Varian Medical Systems (VAR) | United States | $12.098B | 30.92 |
| DexCom (DXCM) | United States | $10.817B | 409.72 |
| STERIS (STE) | United Kingdom | $10.794B | 27.74 |
| Masimo (MASI) | United States | $6.762B | 41.98 |
| Penumbra (PEN) | United States | $4.621B | 261.47 |
| Globus Medical (GMED) | United States | $4.518B | 27.42 |
| Integra LifeSciences Holdings (IART) | United States | $4.381B | 20.62 |
| Wright Medical Group (WMGI) | Netherlands | $3.656B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $3.471B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.338B | 20.57 |
| Cantel Medical (CMD) | United States | $2.780B | 27.65 |
| Glaukos (GKOS) | United States | $2.585B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.241B | 18.22 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.994B | 21.66 |
| Nevro (NVRO) | United States | $1.863B | 0.00 |
| Inogen (INGN) | United States | $1.829B | 36.26 |
| OPKO Health (OPK) | United States | $1.436B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.102B | 0.00 |
| SILK RD MEDICAL (SILK) | United States | $1.091B | 0.00 |
| CryoLife (CRY) | United States | $1.074B | 115.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.046B | 28.42 |
| Accelerate Diagnostics (AXDX) | United States | $1.029B | 0.00 |
| Luminex (LMNX) | United States | $1.000B | 45.37 |
| Veracyte (VCYT) | United States | $0.960B | 0.00 |
| Shockwave Medical (SWAV) | United States | $0.928B | 0.00 |
| Fluidigm (FLDM) | United States | $0.927B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.922B | 175.00 |
| Intersect ENT (XENT) | United States | $0.917B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.903B | 36.95 |
| Natus Medical (BABY) | United States | $0.837B | 17.36 |
| AxoGen (AXGN) | United States | $0.827B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.768B | 26.81 |
| ViewRay (VRAY) | United States | $0.679B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.559B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.514B | 0.00 |
| TransEnterix (TRXC) | United States | $0.436B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.425B | 44.39 |
| Corindus Vascular Robotics (CVRS) | United States | $0.419B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.405B | 0.00 |
| Si-Bone (SIBN) | United States | $0.397B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.375B | 46.36 |
| Accuray (ARAY) | United States | $0.373B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.350B | 0.00 |
| IRadimed (IRMD) | United States | $0.308B | 65.16 |
| Neuronetics (STIM) | United States | $0.288B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.268B | 0.00 |
| Sientra (SIEN) | United States | $0.252B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.208B | 48.17 |
| SOLITON INC (SOLY) | $0.180B | 0.00 | |
| Nuvectra (NVTR) | United States | $0.171B | 0.00 |
| ConforMIS (CFMS) | United States | $0.161B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.152B | 0.00 |
| EDAP TMS (EDAP) | France | $0.142B | 489.00 |
| Alphatec Holdings (ATEC) | United States | $0.137B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.133B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.116B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.110B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 0.00 |
| Vermillion (VRML) | United States | $0.100B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.076B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.072B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.065B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.060B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.057B | 0.00 |
| Electromed (ELMD) | United States | $0.047B | 24.61 |
| Xtant Medical Holdings (XTNT) | United States | $0.038B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.034B | 0.00 |
| Neovasc (NVCN) | Canada | $0.032B | 0.00 |
| Avinger (AVGR) | United States | $0.032B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.032B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.027B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.024B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.022B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.020B | 63.67 |
| American Shared Hospital Services (AMS) | United States | $0.016B | 15.11 |
| Dynatronics (DYNT) | United States | $0.016B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.014B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.012B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.010B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.010B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| Presbia (LENS) | Ireland | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
| ALCON INC (ALC) | $0.000B | 0.00 |
